TABLE 2

Drug-metabolizing activities by recombinant P450 enzymes and tissue microsomes from marmosets, cynomolgus monkeys, and humans

Units of drug oxidation rates by tissue microsomes and recombinant P450 proteins are nmol/min/mg protein and nmol/min/nmol of P450, respectively. Each activity was measured at a substrate concentration of 10 μM (midazolam), 200 μM (alprazolam), 20 μM (nifedipine), 50 μM (testosterone), and 100 μM (bufuralol). Values represent the mean ± standard deviation from triplicate measurements.

Enzyme SourceMidazolam 1′-HydroxylationMidazolam 4-HydroxylationAlprazolam 4-HydroxylationNifedipine OxidationTestosterone 6β-HydroxylationBufuralol 1′-HydroxylationBufuralol 1′-Hydroxylationa
Microsomes
 Marmoset liver3.6 ± 0.20.35 ± 0.030.11 ± 0.013.3 ± 0.21.6 ± 0.10.72 ± 0.02
 Cynomolgus monkey liver1.9 ± 0.10.49 ± 0.010.058 ± 0.0023.8 ± 0.21.8 ± 0.31.7
 Human liver1.5 ± 0.10.13 ± 0.010.016 ± 0.0022.2 ± 0.10.99 ± 0.010.24 ± 0.010.21
 Marmoset small intestine0.95 ± 0.020.075 ± 0.0040.0080 ± 0.00010.32 ± 0.030.15 ± 0.02
 Cynomolgus monkey small intestine1.2 ± 0.10.29 ± 0.010.015 ± 0.0011.1 ± 0.10.47 ± 0.01
 Human small intestine0.77 ± 0.010.082 ± 0.0050.0085 ± 0.00021.2 ± 0.10.58 ± 0.01
Recombinant P450
 Marmoset 3A4 ortholog29 ± 19.1 ± 0.61.4 ± 0.125 ± 158 ± 21.9 ± 0.2
 Marmoset 3A5 ortholog1.2 ± 0.10.051 ± 0.0150.022 ± 0.0051.1 ± 0.25.4 ± 0.31.4 ± 0.1
 Marmoset 3A903.4 ± 0.40.11 ± 0.010.054 ± 0.0062.8 ± 0.14.9 ± 0.70.81 ± 0.01
 Marmoset 2D68.5 ± 0.9
 Marmoset 2D81.9 ± 0.3
 Cynomolgus monkey 3A418 ± 115 ± 11.5 ± 0.133 ± 350 ± 20.99
 Cynomolgus monkey 3A536 ± 12.7 ± 0.30.78 ± 0.0134 ± 260 ± 22.4
 Cynomolgus monkey 2D68.9
 Cynomolgus monkey 2D444.9
 Human 3A411 ± 12.3 ± 0.10.74 ± 0.0222 ± 220 ± 10.13 ± 0.010.41
 Human 3A536 ± 21.4 ± 0.10.46 ± 0.017.8 ± 0.419 ± 10.24 ± 0.010.33
 Human 2D65.8 ± 0.76.1
  • a Enzymatic activities for bufuralol 1′-hydroxylation by liver microsomes and recombinant P450 2D and 3A proteins at a substrate concentration of 200 μM are taken from Emoto et al. (2011).